REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ryvis Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ryvis Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ryvis Pharma Private Limited is an enterprise in India, with the main office in South Delhi. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on November 26, 2008. From the latest financial highlights, Ryvis Pharma Private Limited reported a net sales revenue increase of 46.06% in 2024. There was a total growth of 46.96% in Ryvis Pharma Private Limited’s total assets over the same period.

Legal Address
91 Springboard, B1/H3, Mohan Co-Operativemathura Rd, Industrial Area, Block B, New Delhi, Delhi-110044
South Delhi; Delhi; Postal Code: 110044

Contact Details: Purchase the Ryvis Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ryvis Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Ryvis Pharma Private Limited report to view the information.
Incorporation Date:
November 26, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Ryvis Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
46.06%▲
Total Operating Revenue
44.43%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
46.96%▲
Total Equity
0.99%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo